Arkolith/Insider Trading/KMTS/Form 4

Webster Brian Daniel

See Remarks, DirectorKESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) · full profile →Form 4 · filed Jul 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$337K
Net Open-Market Flow
-$337K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Grant(A)176K—$0572K
Jul 15, 2026Sell(S)11K$22.01$247K561K
Jul 15, 2026Sell(S)784$22.63$18K560K
Jul 15, 2026Sell(S)3K$24.00$72K557K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-308041) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML